Unexplained weight loss (UWL) is a frequent clinical challenge for physicians. It is often associated with underlying serious conditions, including malignancies, gastrointestinal disorders, and endocrine abnormalities. This article aims to provide a comprehensive approach to the evaluation and management of UWL in clinical practice.
UWL can be a manifestation of multiple pathologies. The most common causes include malignancies, chronic infections, gastrointestinal disorders, and endocrine abnormalities. The pathophysiology of UWL is multifactorial and often involves a combination of reduced caloric intake, increased metabolic rate, and malabsorption.
A thorough history and physical examination are essential in the assessment of UWL. The history should focus on the duration of weight loss, associated symptoms, and risk factors for specific diseases. Physical examination should include a comprehensive systemic evaluation to identify any signs of underlying disease.
The diagnostic approach to UWL should be guided by the clinical assessment. Initial investigations may include a complete blood count, metabolic panel, thyroid function tests, and imaging studies. Further investigations should be directed by the initial findings and may include endoscopy, biopsy, or specialized imaging studies.
Management of UWL is primarily directed towards treating the underlying cause. Nutritional support and symptom management are also important aspects of patient care. Early diagnosis and treatment can significantly improve patient outcomes.
UWL is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history, physical examination, and appropriate investigations are crucial in identifying the underlying cause. Timely diagnosis and management can significantly improve patient outcomes and quality of life.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation